|
|
|
|||||||
|
|
||||||||
|
Medical education about wounds and other subjects. |
Presentations |
|||||||
|
|
||||||||
|
Miscellany |
About |
Contact Us |
||||||
|
Certain pages are pending.
Check back again. |
||||||||
|
About: These are the presentations, notes, transcripts,
or other materials from previous lectures and conferences. Many of these files are accessible to all
users. If you are asked for a password
to access certain of these files, you must get the password from the
organization which hosted the presentation. Many
of these files are fully annotated with text to accompany each slide, which
obviously makes them more understandable and educational. Alas, many are not, but periodically some
notes are added. The status is
indicated, starred if annotated. |
||||||||
|
|
||||||||
|
|
||||||||
|
|
|
|||||||
|
2011, April 14 Dallas, TX Lymphoid
Tertiary Auto-Immunization 2011, January 20 Augusta, GA Integrating
New Technologies Into Practice 2011, January 6 Phoenix, AZ Wound
Pathergy – When Not to Operate 2010, May 7-8 Baltimore, MD Integra
Flap Course 2010, February 22-23 Maui, HI The
Physics and Pathology of Wounds ( 3
parts ) 2009, September 26 Miami, FL (Not)
Atypical Wounds & Integrating New Technologies 2009, November 6 Phoenix, AZ Apligraf –
Re-Engineered Living Skin 2006, December 8 St. Thomas, USVI Integra
in Situ Tissue Engineering: Embryonic
Histogenesis 2006, August 12 Squaw Valley, CA Surgical
Treatment & Reconstruction of Necrotizing Infections 2006, May 19 Fort Collins, CO Hypercoagulability –
Pre- & Microthrombotic Disorders 2006, May 16 Scottsdale, AZ Angiogenesis as a Regulated
Control System (the VT Model) 2006, March 8 Palm Springs, CA Apligraf –
Re-Engineered Living Skin
– Chronic Wounds 2005, December 14 Bethesda, MD Integra Artificial Skin –
Geriatric Population 2005, October 29 Phoenix, AZ Wounds
and Ulcers in Geriatric Patients |
||||||||
|
|
||||||||
|
Transcripts,
notes, and slides from the most recent presentations. |
||||||||
|
|
|
|||||||
|
|
Lymphoid Tertiary Auto-Immunization:
The Intrinsic Cause of Failure In Chronic Refractory Wounds, and Restoration of
Wound Healing with Anti-Immune Therapies WHS
meeting 2011 This is a further presentation on the
subject of intrinsic wound pathology and wound failure due to lymphoid
auto-immunization – what happens when some set of primary pathologies
perpetuates injury, thrombosis, and inflammation to the point that a wound
transitions from the state of acute inflammation and wound healing (the
2-population wound) to a state of lymphoid auto-immunization (the
3-population wound). There is little
discussion of physics here, just a focused perspective and concise thesis on
the core clinical issues and histopathology of immunization against the
stroma. Presentation
format (pdf 57 MB).
Full page graphics, without
additional text. Presentation
low-res (pdf 14 MB).
Same file compressed – faster
but jpg artifacts. |
|||||||
|
|
Integrating New Technologies into Practice Joseph
M. This is an
eclectic and philosophical look at the world of new wound products, including
an overview of pharmaceutical history and vulnerary medications. If you are curious how Reader’s
format, PDF (pdf 3 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 28 MB).
*** Full TEXT: small size but
hi-res images. Presentation
format, Powerpoint web (html 30 MB).
Full page graphics, without
text. Presentation
format (pdf 19 MB).
Full page graphics, without
text. |
|||||||
|
|
Wound Pathergy – When Not to Operate Surgery
Grand Rounds presentation given January 6, 2011 at Banner Good Samaritan. This presentation explains the
principles of wound pathergy and the general categories of pathology that
cause thrombo-infarctive and inflammatory-lytic necrosis and ulceration
(vascular, hematological, hypercoagulable, inflammatory, autoimmune). It then explains problems caused by these
diseases, the focus being on the risks for surgery and post-operative wound
failure. Presentation
format, HTML (pdf 16 MB).
No text, slides as presented
January 6, 2011. Original review,
PDF (pdf 2.4 MB).
Text & images from original
thrombocytosis review. Mixed format,
PDF (pdf 18 MB).
The above two combined in one
file. The
current postings are not yet explicitly annotated. This presentation originated as a review of
a case of wound pathergy with thrombocytosis, and the content and case
studies of these two documents is very similar. Until the annotations are completed for the
actual January 6, 2011 presentation, the original review has been posted.
|
|||||||
|
|
Integra Flap Course These
are the two presentations given at the Integra Flap Course. There is no text annotation, just the
presentation slides. Part 1. Principles of
Wound Repair Surgery: Flaps &
Regenerative Matrices Concepts
& Techniques. This begins
with a review of flap principles, the focus being on finer points of
practice. Next is a discussion of
regenerative matrices and how they solve problems when flaps cannot be done. Presentation
format, HTML (html 51 MB).
No text, hi-res images in ppt
format. Presentation format,
PDF (pdf 25 MB).
No text, pdf format. Part 2. Principles of
Wound Repair Surgery: Flaps of The Leg
(& Lower Extremity). Design &
Execution. This
presentation accompanied the laboratory session. It is about flaps of the lower extremity,
explicitly flaps originating on the leg (plus some discussion of thigh
adductor flaps). Presentation
format, HTML (html 21 MB).
No text, hi-res images in ppt
format. Presentation format,
PDF (pdf 10 MB).
No text, pdf format.
|
|||||||
|
|
The Physics and Pathology of Wounds The
John A. Boswick, M.D. Burn and Wound Care Symposium 2010 This 3-part presentation explains the
nature of intrinsic wound pathology and wound failure. Certain chronic wounds fail to heal in
spite of all reasonable treatment.
Why? Furthermore, problems like
arterial insufficiency and pressure either injure or impair and thus inhibit
wounds, but they are factors extrinsic to the inherent wound healing
machinery. What then are the intrinsic
diseases of the wound module? This
series of lectures will explain that the inherent disease of wound healing is
of necessity a disease of fibroblasts, angiocytes, vessels, and connective
matrix, and more specifically a state of auto-immunization against them. How it is that this state then makes the
wound so refractory cannot be explained via any single cellular or chemical alteration,
but rather by the physics of complex systems. Part 1. The Wound as a
System and a Controlled Machine. Part 1
explains the wound as a closed loop control system. It includes a precis of fundamental wound
anatomy and physiology, then it explains the timewise dynamics of wound
healing. In so doing, it also sets the
foundations for understanding the generalities of non-linear dynamics. Reader’s format,
PDF
(pdf 2 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 31 MB).
*** Full TEXT: small size but
hi-res images. Presentation format,
PDF (pdf 20 MB).
No text, mid size file, full
page hi-res images. Part 1:
Presentation format has slides only.
Reader’s versions have full text annotation. Part 2. Auto-Immunopathy
and the Intrinsic Disease of Wound Healing. Part 2 takes
a more conventional biological and pathological look at the impaired wound,
beginning with a review of hypercoagulable and immunopathic ulcers. From there, it explains the origins of
auto-immunopathy in wounds subject to sustained acute inflammation. It then elucidates the kinship of the
impaired wound to the other connective tissue disorder, then concludes with
case studies illustrating these principles. Reader’s
format, PDF (pdf 4 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 60 MB).
*** Full TEXT: small size but
hi-res images. Presentation format,
PDF (pdf 44 MB).
No text, mid size file, full
page hi-res images. Part 2:
Presentation format has slides only.
Reader’s versions have full text annotation. Part 3. Chronicity and
the Physics of Wound Failure. Part 3
combines the science and engineering of Part 1 with the clinicals and
pathology of Part 2 to explain why refractory chronic wounds must be that
way. This understanding cannot be
arrived at by conventional biochemistry and cell biology, but rather by an
understanding of non-linear and population dynamics. It also includes a conspectus of wound
histopathological findings that practitioners can use to study, diagnose, and
plan treatment for wounds in their own practices. Reader’s
format, PDF (pdf 3 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 36 MB).
*** Full TEXT: small size but
hi-res images. Presentation format,
PDF (pdf 25 MB).
No text, mid size file, full
page hi-res images. Part 3.
Presentation format has slides only.
Reader’s versions have full text annotation. Part 4. A Gallery of Case
Studies. Part 4. This is a set of case studies to accompany
the first 3 parts. Part
4 being prepared – taking longer than expected, but it should be up by March
2011. The
following is a prior presentation which includes some of the same, some
different material. It is comparable
to Part 2, and is focused on immunopathic ulcers, coagulopathic ulcers, and
the origins of connective tissue auto-immunity and the appearance of lymphoid
inflammation. (NOT) Atypical Wounds (
Autoimmunopathy and Connective Tissue Disorders: The True Intrinsic Diseases of Wound
Healing ) Reader’s
format, PDF (pdf 4 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 70 MB).
*** Full TEXT: small size but
hi-res images. Presentation format,
PDF (pdf 39 MB).
No text, mid size file, full
page hi-res images. Presentation
format, Powerpoint web (html 90 MB).
No text, full page hi-res
images.
|
|||||||
|
|
(NOT) Atypical Wounds (
Autoimmunopathy and Connective Tissue Disorders: The True Intrinsic Diseases of Wound
Healing ) Baptist
Health Reader’s
format, PDF (pdf 4 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 70 MB).
*** Full TEXT: small size but
hi-res images. Presentation format,
PDF (pdf 39 MB).
No text, mid size file, full
page hi-res images. Presentation
format, Powerpoint web (html 90 MB).
No text, full page hi-res
images.
Integrating New Technologies into Practice Baptist
Health Reader’s
format, PDF (pdf 3 MB).
*** Full TEXT annotation: small
file, low-res images. Reader’s
format, HTML (html 28 MB).
*** Full TEXT: small size but
hi-res images. Presentation
format, Powerpoint web (html 30 MB).
Full page graphics, without
text. Presentation
format (pdf 19 MB).
Full page graphics, without
text. This is an eclectic and
philosophical look at the world of new wound products, including an overview
of pharmaceutical history and vulnerary medications. If you are curious how |
|||||||
|
|
Apligraf – Re-Engineered Living Skin –
Biotechnology and Chronic Wounds Based on presentations 2002 –
2009. Content partially supplied by
Organogenesis. Apligraf is
a laboratory grown living skin equivalent.
It is used as a “living pharmaceutical” on select problem wounds. It has an effect to induce or accelerate
wound healing. Reader’s
format, PDF (pdf 7.5 MB).
Partial text annotation. Presentation
format, PDF (pdf 23 MB).
No text, full page hi-res
images. This talk is partially annotated.
|
|||||||
|
|
||||||||
|
Transcripts,
notes, and slides from older presentations. |
||||||||
|
|
||||||||
|
GAP |
Files and presentations from this
interval are coming soon. Main
subjects include: Immunopathies
and Wounds Pediatric
Wounds Abdominal
Wall Reconstruction Cadaveric
Regenerative Matrices 21st
Century Medicine and Surgery Wounds
– A Philosophy of a New Specialty In
Situ Tissue Engineering & the Fourth Paradigm of Surgery
|
|||||||
|
|
In Situ Tissue Engineering With
Integra: Embryonic Histogenesis in
Regenerative Matrices. Wound Healing Science & Industry,
7th Annual Meeting Slide version (ppt
6.8 MB). Not annotated Powerpoint web
presentation (html 12 MB).
Not annotated
|
|||||||
|
|
Surgical Treatment and Reconstruction of Necrotizing Soft Tissue
Infections. MSIS
– Musculoskeletal Infection Society, 16th Annual Meeting Slide version
(ppt 4 MB).
*** Complete, with text annotations. Powerpoint web
presentation (html 4 MB).
*** Complete, with text annotations. Reader’s format (html
18 MB). ***
Complete, with text annotations. Slides &
text (pdf 5.4 MB). *** Complete, with text annotations.
|
|||||||
|
|
Hypercoagulability – Prethrombotic and Microthrombotic
Disorders.
Slide version
(pdf 11 MB).
Not annotated.
|
|||||||
|
|
Angiogenesis
as a Regulated Control System (the VT Model) WHS
– Wound Healing Society, 16th Annual Meeting Slide version (pdf 16MB).
Not annotated.
The
Wound as a Non-Linear Control System Poster version
(pdf 4.5 MB).
Not annotated. Hypercoagulability – Prethrombotic and Microthrombotic
Disorders. Poster version
(pdf 2 MB).
Not annotated.
|
|||||||
|
|
Apligraf – Re-Engineered Living Skin –
Biotechnology and Chronic Wounds Sponsored
by Organogenesis Powerpoint
version (ppt 23 MB). Slides and partial annotation. Annotated page
version (pdf 7.5 MB) Slides and partial annotation.
|
|||||||
|
|
Integra Artificial Skin – Geriatric Population CMS - Medicare. Slide version
(pdf 13.4 MB).
Not annotated.
|
|||||||
|
|
Wounds and
Ulcers in Geriatric Patients Arizona Geriatrics Society,
17th Annual Meeting Slide version
(pdf 16 MB).
Not annotated.
|
|||||||
|
|
||||||||
|
|
||||||||
|
Terms of use: The materials on this website are
copyrighted, with all rights reserved to their respective contributors. The materials on this site are provided for
educational purposes only. Content
files, text, and illustrations may all be downloaded and used freely for
educational purposes. This includes
typical academic and instructional activities such as symposia and classroom
presentations, book chapters and other printed instructional materials,
etc. If materials from this site are
used for such purposes, acknowledgement and attribution are expected. These materials may not be plagiarized nor
may they be reprinted without attestation.
They may not be sold or used for commercial purposes. Favorable comments about products and companies
does not constitute an explicit endorsement, and the use of Arimedica materials
for commercial purposes requires prior consent (with the exception of
bibliographic citations, fair use reprints of small amounts of material, or
other customary references as would be used to fairly and legally acknowledge
any other publication). |
||||||||
|
|
|
|||||||
|
Arimedica Phoenix, |
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
Miscellany |
About |
Contact Us |
||||||
|
© Copyright 2005 - 2011, Arimedica, All rights reserved. |
||||||||
